About TB-500 Order

What this site is

TB-500 Order is an independent editorial project that publishes summaries of the peer-reviewed research literature on TB-500 — the synthetic Ac-LKKTETQ fragment of thymosin beta-4 — and on the parent protein itself. We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.

The site is built around one discipline: keeping the measured apart from the marketed. "TB-500" denotes a 7-amino-acid fragment, but most of the published efficacy data are for full-length thymosin beta-4 — so every finding here is flagged for which molecule it actually used ^[7]. Where the human evidence stops, we say so.

About the name

The word "Order" in the name is editorial, not transactional. It refers to the work this digest does — ordering a scattered literature into something a reader can follow: a mechanism, the strongest animal findings, the safety signal, and the current regulatory status, each cited to source. It is not a checkout, an inventory, or an offer to supply anything. The negative space on every page is deliberate; this is a reading surface, not a storefront.

The TB-500 legal status page exists for the same reason — to state, from the FDA record, where the substance stands today, rather than to route anyone toward obtaining it.

How we cite

Every quantitative claim on this site — a dose, a percentage, an n-value, a route, a date — maps to a numbered entry on the full study references page, drawn from PubMed-indexed journals, ClinicalTrials.gov, and FDA pages. Research findings are described as what was administered to which species at which dose by which route. Nothing here is a dosing recommendation for any person, and nothing here is medical or legal advice.

We also try to be explicit about absence. "No completed controlled human trial of the fragment" is a finding, and we state it as plainly as we state a positive result ^[7]. A digest that only reports what looks promising is not a digest of the literature; it is a brochure. The structure of every research page here — a mechanism, the strongest animal data, the safety signal, the human-evidence gap, the regulatory status — is built so the gaps are as visible as the findings.

The domain modifier

The site's name carries a modifier — "order" — that on many pages of the wider web signals a transaction. Here it does not. We do not employ doctors, pharmacists, or any healthcare staff; we do not offer treatment, consultation, or prescription services; and the modifier is editorial framing — a position this publisher occupies relative to the literature, putting it in order — not a claim about services the site provides. If you are looking to obtain TB-500, this is not that site; what it offers is a cited reading of the research and the current regulatory record.